skip to content
Dovepress - Open Access to Scientific and Medical Research
View our mobile site

8852

Quantitative determination of glycosaminoglycans in tears of diabetic patients

Original Research

(2170) Views  (510) Full article downloads

Authors: Marilita M Moschos, Alexandros A Rouvas, Spyridon Papadimitriou, Athanasios Kotsolis, Nikolaos Sitaras, Michael Apostolopoulos

Published Date October 2008 Volume 2008:2(3) Pages 581 - 584
DOI: http://dx.doi.org/10.2147/OPTH.S2643

Marilita M Moschos1, Alexandros A Rouvas1, Spyridon Papadimitriou1, Athanasios Kotsolis1, Nikolaos Sitaras2, Michael Apostolopoulos1

1Department of Ophthalmology; 2Department of Pharmacology, University of Athens, Greece

Purpose: To determine the amount of glycosaminoglycans (GAGs) in tears of patients with diabetic retinopathy (DR) and to compare it with normal subjects.

Methods: 38 patients with DR and 24 normal volunteers were included. Thirty subjects suffered from background diabetic retinopathy (BDR) and 8 from proliferate diabetic retinopathy (PDR). For the GAGs assay, the uronic carbazole reaction was used.

Results: The mean concentration of GAGs was significantly higher in patients with DR than in normal subjects. The GAGs concentration in patients with BDR or PDR was significantly higher than in normal subjects.

Conclusion: The measurement of GAGs in tears of diabetic patients could be a tool in order to assess the stability or not of the disease.

Keywords: glycosaminoglycans, tears, diabetic retinopathy






 

Other articles by Dr Marilita Moschos



Readers of this article also read:

Intravenous zoledronic acid for the treatment of osteoporosis: The evidence of its therapeutic effect
Comparison of once-daily versus twice-daily dosing of valsartan in patients with chronic stable heart failure
Advances in diagnostic and treatment options in patients with fibromyalgia syndrome
Functional mobility and balance in community-dwelling elderly submitted to multisensory versus strength exercises
Clinicoradiological features of recurrent ischemic stroke: healthcare for poststroke patients
Baseline characteristics and initial treatment decisions for patients with schizophrenia at risk of treatment nonadherence
Anesthesiologists’ perception of patients’ anxiety under regional anesthesia
Saxagliptin: the evidence for its place in the treatment of type 2 diabetes mellitus
Retinal nerve fiber layer evaluation in multiple sclerosis with spectral domain optical coherence tomography
Erratum - Intracellular heavy metal nanoparticle storage